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AbstrACt
Objectives To review the progress of public involvement 
(PPI) in NIHR (National Institute for Health Research) 
research, identify barriers and enablers, reflect on the 
influence of PPI on the wider health research system in 
the UK and internationally and develop a vision for public 
involvement in research for 2025. The developing evidence 
base, growing institutional commitment and public 
involvement activity highlight its growth as a significant 
international social movement.
Design The ‘Breaking Boundaries Review’ was 
commissioned by the Department of Health. An expert 
advisory panel was convened. Data sources included: an 
online survey, international evidence sessions, workshop 
events, open submission of documents and supporting 
materials and existing systematic reviews. Thematic 
analysis identified key themes. NVivo was used for data 
management. The themes informed the report’s vision, 
mission and recommendations, published as ‘Going the 
Extra Mile—Improving the health and the wealth of the 
nation through public involvement in research’. The Review 
is now being implemented across the NIHR.
results This paper reports the Review findings, the first 
of its type internationally. A range of barriers and enablers 
to progress were identified, including attitudes, resources, 
infrastructure, training and support and leadership. 
The importance of evidence to underpin practice and 
continuous improvement emerged. Co-production was 
identified as a concept central to strengthening public 
involvement in the future. The Vision and Mission are 
supported by four suggested measures of success, reach, 
refinement, relevance and relationships.
Conclusions The NIHR is the first funder of its size and 
importance globally to review its approach to public 
involvement. While significant progress has been made, 
there is a need to consolidate progress and accelerate 
the spread of effective practice, drawing on evidence. 
The outcomes of the Review are being implemented 
across the NIHR. The findings and recommendations 
have transferability for other organisations, countries and 
individuals.
bACkgrOunD 
Introduction
Public involvement is becoming an increas-
ingly important feature of health research, 
nationally and internationally. Public involve-
ment—as defined by INVOLVE and adopted 
for the National Institute for Health Research 
(NIHR) Review in England is undertaken 
‘with’ or ‘by’ patients or members of the 
public, rather than ‘to’, ‘about’ or ‘for’ them.1 
It can mean people becoming members 
of the research team, or part of reference 
groups, involved in key discussions and 
decisions, sharing their unique knowledge, 
expertise and perspective. For example, they 
may be involved in identifying key research 
questions, planning study designs, selecting 
appropriate outcome measures, collecting 
data, analysing and interpreting data, dissem-
inating and implementing results.1 This active 
involvement is different from people partici-
pating as passive subjects in clinical trials with 
little contribution to identifying its need, 
designing, conducting or interpreting the 
trial. It also differs from public engagement 
which creates a dialogue between researchers 
and the public to improve public awareness 
and understanding about research.2 The 
intention of public involvement is to prior-
itise and create research that is relevant, 
acceptable and appropriate from the patient 
strengths and limitations of this study
 ► The National Institute for Health Research (NIHR) is 
the first funder of its size and importance globally to 
review its approach to public involvement.
 ► The breadth of the evidence collected including from 
patients, carers and the public, NIHR facilities and 
institutions, other funders and research organisa-
tions and international initiatives.
 ► Evidence-based policy development that is now be-
ing implemented.
 ► Review primarily focused on research activities of 
the NIHR.
 ► Further exploration required to assess equivalence 
of themes in international contexts.
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or public perspective.3–6 It may be more likely to be imple-
mented, creating greater impact on health and well-
being, particularly if patients also have an active role in 
implementation.7 It can also help avoid waste in research 
by ensuring it focuses on issues of importance and benefit 
for patients,8 so maximising the potential for democratic 
accountability to the wider public, who fund a significant 
proportion of UK research.
Public involvement is growing as a movement in the UK, 
Canada, Australia, Europe and the USA. For instance, in 
the USA, the Patient Centred Outcomes Research Insti-
tute (PCORI) encourages patients to submit research 
questions, provide input on funding applications, partic-
ipate in events and become an ambassador, reflecting 
many aspects of NIHR activity.9 The developing evidence 
base, and growing institutional commitment to public 
involvement, highlights its growth as an international 
social movement, gathering strength and creating signif-
icant changes in how research is conducted.10 Public 
involvement is focusing on how individuals, communi-
ties and patient groups can co-produce with researchers 
and health professionals, knowledge that will underpin 
their care and treatment. The potential benefits of public 
involvement in research and on researchers, patients 
and the wider community have been identified.4–6 The 
beneficial impacts of public involvement on research, 
researchers, patient and communities include the: iden-
tification of patient-relevant topics; grounding of studies 
in the day-to-day reality of patient experience, enhancing 
the relevance and appropriateness of studies; identifica-
tion of patient important outcome measures and solving 
challenges in securing informed consent. For patients 
and the public benefits include: feeling listened to and 
empowered; increased confidence and self-worth and 
enhanced skills for self-management.4–6 Patients involved 
in research can also benefit in a number of ways which 
can improve their experience of care.11–13 In summary, 
public involvement has been found to have a significant 
role to play in improving the effectiveness and efficiency 
of research14 and community and patient empowerment 
are seen as critical elements in helping the NHS meet 
future challenges.15
Nonetheless, in spite of the emerging evidence base for 
public involvement over the last 20 years, and a notice-
able increase in the number of papers published more 
recently, challenges remain. These include the quality 
and utility of the evidence base for practice, including 
poor conceptualisation, varied definitions, limited 
capture or measurement of progress of public involve-
ment (PPI) impact and relatively few studies looking at 
later outcomes of PPI in research.4–6 A significant diffi-
culty is inconsistent reporting of PPI, with studies often 
providing partial reporting of their aims, methods and 
results of PPI in their studies, limiting our understanding 
of them.16
In addition, the practice of PPI is not unproblem-
atic and there is still a significant need to attend to the 
cultural barriers that inhibit PPI from being completely 
embedded in research. A recently launched International 
PPI Network is attempting to create significant culture 
change in the world of research.10 In addition, we need 
to acknowledge that PPI is not always a positive experi-
ence with negative impacts reported, particularly on the 
people involved, if carried out poorly.4 17 In addition, the 
tokenism that can exist has been highlighted and the 
narrowness of current PPI models, with few organisations 
mentioning empowerment or addressing equality and 
diversity in their involvement strategies.18 The potential 
for poor practice and negative impact made it even more 
important we undertook the Review to find out how far we 
have progressed and to understand the current barriers 
as well as the enablers.
the uk context
In the UK, the NIHR pioneered a strong policy approach 
to public involvement including high level support from 
the Chief Medical Officer.19 It also established an organ-
isational infrastructure and system for its advancement, 
delivery and support and INVOLVE, the NIHR funded 
national advisory group for the promotion and advance-
ment of public involvement. The resulting environment 
has enabled public involvement to flourish and become a 
strategic priority for NIHR. Professor Dame Sally Davies 
(Chief Medical Officer) said,
‘No matter how complicated the research, or how 
brilliant the researcher, patients and the public al-
ways offer unique, invaluable insights. Their advice 
when designing, implementing and evaluating re-
search invariably makes studies more effective, more 
credible and often more cost effective.’20
the need for the review
After 10 years of the NIHR promoting and advancing 
public involvement across its growing infrastructure and 
associated activities, there was a need to review progress 
within a UK and international context and to develop a 
vision for the future and to identify cultural and organisa-
tional development required to fulfil the vision of public 
involvement.
This was particularly important because the extent to 
which policy support for PPI in health research results 
in any actual influence on health research agendas also 
remains unclear.21 In addition, progress has been rela-
tively slow in funders recognising the importance of 
funding the substantive development of the PPI evidence 
base, as opposed to funding the practice of PPI as a stream 
of activity within a study.
As a result, the ‘Breaking Boundaries Review’ was 
announced by the Department of Health on 31 March 
2014 and reported as ‘Going the Extra Mile’2 a year later. 
It was the first such Review by the NIHR of its public 
involvement work and the first of its type internationally. 
It was designed as an open and collaborative exercise 
involving patients, the public, other funders and partners 
nationally and internationally. The Review Group also felt 
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the need for the policy review to be evidence-informed in 
examining progress made and in developing a vision for 
the future.
Aims of the review
1. To review progress made in public involvement in re-
search the UK.
2. To develop a vision for public involvement in research 
for 2025 and set objectives for the NIHR’s leadership 
in public involvement.
3. To identify cultural and organisational development 
required to fulfil the vision of public involvement as 
an embedded component of health research in NIHR.
MethODs
review Panel
A Review Panel was established to shape the Review. 
Members’ expertise included research, policy, research 
management and patient and public involvement. All 
members of the panel, including the service users were 
involved in the planning of the Review, design of the 
survey, analysis and interpretation and in planning the 
evidence sessions. Three members were service users. A 
full list of members is provided in (online supplementary 
appendix 1).
ethical aspects
While formal ethical approval was not sought through 
an NHS ethics committee for this policy review, it was 
conducted according to Health Research Authority 
(HRA) principles of good ethical conduct in research 
which were applied to relevant stages of the Review. 
Respondents were invited to read an information sheet 
about the Review before participating. All respondents 
were assured of anonymity and confidentiality, unless 
they gave explicit permission to be quoted. Any identi-
fying information was removed from quotes used within 
the main report and publications. All submissions were 
stored on the NIHR CLAHRC Northwest London Impe-
rial College computer system in password protected files.
Collection of evidence, experiences and perspectives
The Panel carefully considered the type of evidence and 
information required to address the aims of the Review. 
The intention of this policy review was not to undertake 
a review of literature but to be informed by key studies 
and systematic reviews. There were no formal criteria for 
inclusion. All members of the Review Group were asked 
to identify key papers they thought were relevant to the 
Review. Moreover, the expert Panel also recognised the 
importance of developing a rigorous process of data 
collection and analysis, to contribute to high quality 
evidence-informed policy recommendations. However, 
it was also felt that a wider collection of evidence, 
experience and perspectives was necessary, in order to 
adequately address the Review questions and to meet the 
NIHR’s public involvement values and principles. Five 
key approaches were selected to facilitate the breadth 
of evidence collection, nationally and internationally, 
summarised in box 1.
Online questionnaire
A survey monkey online questionnaire was developed 
in collaboration with the Panel to minimise respondent 
burden and maximise response. Five key questions were 
posed to respondents. These were felt by the Panel to 
align with the aims of the Review and its key themes. The 
survey questions were also made available as a download-
able word document which could be completed elec-
tronically or by hand and posted. A purposive sampling 
strategy was used to identify a wide range of potential 
respondents, including individuals and organisations, 
with the intention of maximising variation in response.19 
Individuals and organisations targeted included patients 
and members of the public, researchers, clinicians, 
researchers, user-groups, patient organisations, charities 
and policy makers nationally and internationally. The 
initial email with the link to the on-line survey was sent 
to a range of individuals and organisations, who were 
asked to cascade it to others nationally and internation-
ally. It was also available on the NIHR INVOLVE website. 
It was not possible to identify a final sample size because 
the email was cascaded through the public involvement 
community and within the NIHR.
Audio and video evidence
Potential respondents to the call for evidence were 
offered the opportunity to submit evidence in other 
formats including audio and video, although no respon-
dents opted for this.
Document review
Key documents including papers from the NIHR 
INVOLVE bibliography such as key systematic reviews 
and grey literature were used to underpin the Review. 
No systematic review was undertaken due to limited 
resources. Instead Review Group members and respon-
dents provided key papers, reviews and reports to provide 
appropriate background and ensure the underpinning 
evidence base was considered.
International, third sector and industry evidence
In addition to written submissions, the Review Panel 
requested input from international colleagues, the third 
sector and pharmaceutical industry. In total, three panels 
convened, one panel focusing on international perspec-
tives, one focusing on industry views and one focusing 
box 1 A summary of methods of data collection
1. Online questionnaire.
2. Audio and video evidence.
3. Document review.
4. International, third sector and industry representatives evidence 
panel sessions.
5. Workshops, meetings, social media.
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on third sector opinion. Participants were selected based 
on the knowledge of Review Panel members. The role 
of the panels was to provide perspectives, insights and 
any relevant information rather than to have an active 
involvement role. A set of questions were developed 
by the Review Panel to support discussion with invited 
experts which focused on the broader impact of NIHR’s 
public involvement strategy, progress in different sectors, 
perspectives on how successful the NIHR had been, gaps 
in provision and areas where it had been less successful.
Workshops, meetings, social media
Members of the Review Panel joined four workshops 
hosted by the research team undertaking a key NIHR 
PPI study called RAPPORT22 in order to gather evidence. 
Meetings were held in London, Cambridge, Bristol and 
Newcastle. Social media was used to publicise the Review, 
generate debate and encourage submission. An addi-
tional workshop was conducted with representatives from 
medical charities hosted by Parkinson’s UK in London. 
The discussions from workshops, meetings and social 
media provided a wider context for the Review and its 
final recommendations but they were not included as 
part of the NVivo analysis.
Patient and public involvement
Box 2 reports PPI using the BMJ Open criteria and 
(online supplementary appendix 2) reports PPI using 
GRIPP2 Short Form.
Analysis
Data submitted to the Review via the online survey, by 
email and post was managed using NVivo software for 
analysis. Thematic analysis was used to identify key themes 
emerging from the data.23 Information provided through 
other methods was not included in this analysis, but rather 
provided wider context. A particular focus was on iden-
tifying common issues and whether narrative patterns 
emerged across themes and whether any patterns related 
to the source of the evidence. Once a submission was 
received, it was logged and given a unique number and 
saved to the electronic password protected folder on the 
Imperial system. Initial thematic analysis was conducted 
by RM to identify recurrent or common themes. This 
included responses to the Review questions and the 
submission of any ‘open’ evidence. A formative summary 
was developed by RM of emerging themes, which included 
a high level summary in the context of the volume and 
sources of evidence. SS, VM and SD checked meaning and 
interpretation. The emerging themes were discussed with 
the Panel to check the interpretation of categories and 
themes. In order to further structure the analysis RM, SS 
and VM developed the emerging themes into a coding 
framework. The data were then analysed according to this 
framework. Development of themes continued until data 
saturation, the point at which no new major themes are 
evolving.23 As the key themes were identified, SD, with RM, 
SS and VM identified broader conceptual themes which 
captured core components of the evidence submitted 
and provided the conceptual underpinning of the future 
vision and mission. Panel members also drew on the wider 
evidence which was documented from the discussion 
with the international, industry and third sector panels, 
the regional RAPPORT workshops and workshop with 
medical charities. Two meetings were held with the Review 
Panel to scrutinise all available evidence, review interpre-
tations of data and prioritise the report themes.
results
Eighty-two responses were received from an individual, 
institutional, organisational or collective perspective 
with some submissions representing the combined views, 
with table 1 reporting respondent characteristics. These 
included submissions from different parts of the NIHR, 
medical research charities, universities, industry and 
third sector bodies. A total of 538 people responded to 
the online survey. Oral evidence sessions were held with 
colleagues from USA, Denmark, Germany, Canada and 
Australia.
Key aspects of Review results are reported in this paper, 
focusing on positive impacts of PPI, barriers to PPI and 
then explore how PPI can be undertaken differently. 
Future delivery is considered and the resulting vision and 
mission are presented.
nIhr and InVOlVe as positive influences
The evidence indicated that the NIHR’s commitment to 
include the public in research activity has strengthened 
box 2 bMJ Open patient and public involvement reporting 
criteria
•  How was the development of the research question and outcome 
measures informed by patients’ priorities, experience and preferences?
The question was identified by the Review Panel who included patients. 
Patients had a key role in shaping the review questions, the methods, the 
interpretation of the data and the formation of key recommendations.
• How did you involve patients in the design of this study?
Patients shaped the design of the review, contributing to the design of 
the methods for data collection. Patients particularly emphasised the 
importance of qualitative data collection to capture experiences and 
perspectives.
• Were patients involved in the recruitment to and conduct of the study?
Patients were involved with other panel members to identify and recruit 
participants. The survey link was cascaded through snowball sampling 
by patients and PPI leads to key contacts and organisations nationally 
and internationally.
• How will the results be disseminated to study participants?
The study findings will be disseminated through multiple chan-
nels including publication, meetings, conferences, social media and 
through the dissemination plan for NIHR to actively implement the 
recommendations.
• For randomised controlled trials, was the burden of the intervention 
assessed by patients themselves?
Not applicable.
•  Patient advisers should also be thanked in the contributor ship 
statement/acknowledgements.
Patient contributors are thanked in the acknowledgment statement.
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over the last 10 years and that the presence and activi-
ties of INVOLVE has been important in achieving this. 
In addition, patients and carers reported a range of posi-
tive impacts including gaining insight into the research 
process and learning more about conditions and treat-
ments. They also reported positive relationships with 
researchers and welcomed the opportunity to gain new 
experiences, knowledge, skills and contacts. For example:
‘It has given me a platform to represent the views of 
carers and service users in the design and implemen-
tation of research. It has given me a role in life as a 
lifelong carer I have often felt apart from the world 
of work and have before my PPI work floated without 
a purpose.’ ID 156 Public
Researchers identified a range of positive impacts 
including changing their research focus to make it more 
relevant to patients, altering study designs to take account 
of experience and improved recruitment. Researchers 
reported feeling more purposeful and connected to the 
potential beneficiaries of research.
‘It has helped to keep my research close to the con-
cerns of service users. Working with service user re-
searchers in designing studies has been important 
in keeping the research questions and methodology 
focused on the concerns of those who will ultimately 
benefit.’ ID 332 Researcher/Academic
relevance and usefulness of research with public involvement
Respondents including those from third sector organ-
isations reported that involvement could result in 
researchers being more likely to address issues of rele-
vance to those with direct experience of a condition, 
treatment and care. Respondents also described aspects 
of personal transformation such as gaining new knowl-
edge, changing attitudes and adopting different ways of 
doing things for example,
‘It has enabled increased recruitment through access 
to hard to reach and minority groups. It has ensured 
that public facing research materials are accessible 
and understandable for lay people—again, this in-
creases recruitment. It has enabled evaluation of the 
experience of those participating in health research—
and subsequent trial design has improved, again in-
creasing recruitment. It has ensured where possible 
that research outcomes are disseminated in a timely 
and accessible way—resulting in a more informed 
patient population.’ ID 91 Public Involvement Lead/
Specialist
bArrIers tO PublIC InVOlVeMent In reseArCh
Respondents identified a range of ongoing barriers to 
public involvement including public awareness, atti-
tudes, resources, infrastructure, recognition, reward and 
payment and resources and training.
Public awareness
Although there was greater awareness of public involve-
ment in research, it was felt that opportunities were not 
accessible to the wider population. Evidence submitted 
by those working in public health particularly emphasised 
the risk of reinforcing inequalities and missing opportu-
nities to improve health in communities with the most to 
gain.
‘I think the whole “public involvement” side of things 
is very good at the moment. However, the information 
(online) about it, such as the opportunities available 
and how to apply, could be simplified’. ID 32 Public
Many commented on the need for a high profile and 
well-crafted communication campaign to raise awareness 
of health research and demystify the activity in a way that 
the general population could engage with;
‘People need to know what is out there, how they can 
get involved and why it's happening. The acronyms, 
that then need to be spelt out and explained along 
with the many avenues an opportunity comes from, 
suddenly gets too difficult to decipher unless you’re 
an academic or a clinician… ID 227 Other
resources
Variability in the availability and allocation of resources 
to support involvement was a common theme. There was 
frustration that funding to support relationship building 
and partnership work ahead of preparing funding 
applications could be difficult to obtain, but was vital in 
providing an acceptable standard of good involvement 
practice in the early stages of research design.
Infrastructure
As public involvement has grown across the NIHR, vari-
ation in the infrastructure to support activity has arisen. 
This raised questions about how infrastructure decisions 
Table 1 Respondent characteristics
Respondent characteristic Number %
Public (service user/patient/consumer/
carer)
174 40
Researcher/academic 100 23
Other research role (eg, research manager, 
commissioner)
39 9
Voluntary sector 27 6
User researcher 24 6
Public involvement lead/specialist 52 12
Clinician/practitioner/service provider or 
manager
11 3
Other 6 1
Total 433 100
Unknown 105 –
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are made, what evidence is available about effective 
models and to what extent public involvement practice 
across the NIHR and the NHS can be aligned.
‘There is far too much duplication, working in silos 
and re-inventing the wheel. We need to free ourselves 
up to enable more time and resources for innova-
tion and creativity. This needs to be joined up with 
academic and NHS public involvement strategies so 
that patients have one gateway into involvement op-
portunities and clear signposting from there’. ID 526 
Public Involvement Lead/Specialist
recognition, reward and payment
Another significant barrier was the issue of recognition, 
reward, reimbursement and payment. Despite the avail-
ability of guidance, local NHS and Higher Education 
Institutional policies and administrative practices could 
be problematical which could slow down prompt reim-
bursement and payment. Current austerity policies added 
to those challenges. There is a risk that those who get 
involved are those who can afford the time and money to 
do so, compounding issues of exclusion.
‘Established groups can provide a wide range of 
support (research design, pre-funding through to 
dissemination… However, finance for groups such 
as these is precarious and without sustained and ad-
equate funding it is difficult for groups to continue 
to develop and expand their contribution despite 
the increased requirement for PPI if bids are to be 
successful. Core funding is needed to fund admin-
istrative support of the group as well as advertising, 
outreach work, mentorship and training of current 
and new members. ID 29e Researcher/Academic
training and support
Many respondents commented on the need for training 
and support for public involvement. There was broad 
agreement that a basic level of support should be available 
to anybody who becomes involved and a minimum skill 
level and knowledge about public involvement should 
be incorporated into researcher training. It was acknowl-
edged there is still significant development needed to 
embed PPI into the research culture in terms of training.
‘Currently the training provided is basic, to ex-
plain what PPI is and help researchers plan how to 
proceed (I have taught on such workshops). ID 74 
Researcher/Academic
‘Training early career researchers in good involve-
ment practice would help increase confidence and 
understanding of public involvement and reduce the 
likelihood of bad involvement experiences… ID 19e 
Charity
Inconsistency in approach
Some respondents identified difficulties of translating 
evidence of effective PPI into practice and noted the 
evolution of ad hoc practice. Many individuals and teams 
work independently of each other even within the same 
organisation, institution or region although there are 
areas where a more collaborative approach is emerging. 
For some there is a desire to introduce standards while for 
others a systematic but flexible approach which addresses 
key elements such as ‘why’, ‘how’ and ‘who’ would be 
more helpful.
Making all involvement opportunities task specific, 
time-limited, with clear expectations and guidance on 
what people should expect from being involved and 
how their input will be qualified (eg, two-feedback/
appraisal process on how people are performing). 
Providing information on outcomes of previous, rel-
evant research and examples of how PPI was crucial 
to the effectiveness of the research trial. ‘ID 91 Public 
Involvement Lead/Specialist
While frameworks for planning evaluations exist, the 
approach to evaluating PPI was varied and inconsistent.
One would be at the start of a study, to plan ahead how 
to evaluate the impact of PPI on the research, and on 
the contributors (cf. the PiiAF – Public Involvement 
Impact Assessment Framework document). The sec-
ond would be, with other researchers and PPI rep-
resentatives acting as 'critical friends', to reflect on a 
study at the end and thus to work out what to do bet-
ter next time. ID 74 Researcher/Academic
Some respondents highlighted increasing pressure to 
demonstrate the impact of PPI and ensure it forms part 
of a University submission to the Research Excellence 
Framework, the evaluation of research quality in England 
and Wales.
leadership
A supportive, competent and influential leadership was 
perceived as critical to the successful delivery of involve-
ment. Respondents commented on the value of expe-
riential knowledge of public involvement in leaders. 
Conversely, perceived lack of first–hand experience of PPI 
and limited or absent empathy with patients were thought 
to diminish the status of some research leaders. It was 
suggested that champions of involvement are required 
from outside established involvement teams to promote 
changes in organisational and institutional culture.
Challenges
A number of respondents reported poor experiences 
with PPI including a general sense of frustration from 
engaging with research, understanding the NIHR and how 
it links to services. There was also confusion around how 
to access information and opportunities about becoming 
involved, suggesting a varied picture of personal practice, 
organisational commitment and institutional culture.
‘I wholeheartedly agree with the intentions and prin-
ciples of PPI… Unfortunately, I think that lip service 
is given to PPI by some academics. There is a lack 
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of transparency about how service users who are in-
volved in research studies are selected, approached, 
recruited and what biases might be operating.’ ID 15 
Researcher/Academic
…Some organisations are in a frenzy of PPI because 
they know they have to do it not because they want to. 
ID 260 Public
scepticism, professionalisation and confusion
Respondents reported a range of challenges when they 
undertook public involvement, including scepticism 
about its value, uncertainty about its underpinning 
theoretical concepts and unclear practice standards. 
Challenges also included individuals feeling confusion, 
apprehension and anxiety about how to conduct involve-
ment in a way that demonstrated a positive impact. 
Researchers were sometimes wary of using experienced 
advisers because they perceived that the very experience 
those individuals started from may evolve and be diluted 
over time. Others felt the development of such specialist 
expertise was important and had a beneficial impact.
‘PPI architecture tends to call for a small number 
of individuals to make a massive commitment. This 
means it is hard to find people who can do it and 
those who do come forward are probably not repre-
sentative of the wider population. We should try to 
design more distributed systems which are less clunky 
and more dynamic (more ‘Web 2.0’). Instead of peri-
odic half-day meetings, break things up into smaller 
modules/components that can be distributed among 
more people so it is less of a burden for each person. 
This could allow more people to get involved and it 
would democratize PPI.’ ID 216 Public Involvement 
Lead/Specialist
While a range of barriers were identified and challenges 
were identified, respondents recognised that progress in 
developing and embedding PPI across the NIHR had 
been made. This had raised the profile of public involve-
ment, established aspects of good practice and made a 
difference for patients and their families by ensuring 
research was more meaningful and focused on improved 
outcomes.
DOIng PublIC InVOlVeMent DIfferently
Respondents identified new ways of approaching involve-
ment, reflecting a broad range of experience now 
emerging across the NIHR. A number of key areas for 
future development emerged.
Practice standards
There was a perceived need to consolidate and use the 
available evidence to identify gaps in knowledge. The 
use of continuous improvement was suggested as way 
to improve practice standards alongside peer review, 
performance management, self-regulation and indepen-
dent regulation. The practice standards have now been 
launched by INVOLVE and were developed through a 
consultation process. They provide important guidance 
and form the basis for continuous improvement.
Promotion and outreach
Some respondents expressed a desire to extend and 
deepen the wider involvement of the general population 
in health research.
‘The sense that getting involved in medical research 
is an aspect of being a good citizen. I think we 
should foster a sense that the public have a right to 
participate and, at a minimum level, perhaps even a 
duty…I think we should build a sense of reciprocity. 
The public help by volunteering for trials so what 
does the public get back? …The public pays the go-
ing rate for the medicines via the tax system and the 
NHS. …So I think the reciprocity should come in 
the form of a bigger say in the direction and shaping 
of research. ID 216 Public Involvement Specialist/
Lead
Diversity and inclusion
Current involvement practice was perceived by some as 
being exclusive and not always fully meeting the require-
ments and goals of equality legislation. Respondents 
suggested a range of improvements:
‘Shorter interactive and more accessible involvement 
so that everyone can join’. ID 525 Young People 
Advisory Group Researcher Adviser
‘This is difficult for many organisations. Seeing role 
models like themselves—old/young, non-white, not 
wearing grey suits—all these would help. People from 
unrepresented areas may believe that it's not for the 
likes of them to get involved so showing people who 
are like them, getting on and making a difference, is 
likely to be helpful.’ ID 29 Public
Respondents also commented on the need for involve-
ment to more closely reflect diversity in the population. It 
was felt that if leaders and role models were promoted and 
recruited from varied backgrounds, this would encourage 
more people to become involved.
‘Be more aware of community centres, faith centres 
as sources of research participants. Acknowledge 
public health expertise in their local communities; 
community support officers etc. Get Healthwatch in-
volved. Local radio stations (eg, we have had health/
health research message put over local Punjabi ra-
dio) Research in the evenings? Weekends? Think 
differently about when research is done and where 
it is done. Think who are we going to get participat-
ing at that time? The times are usually convenient for 
the researchers rather than the participants. Make it 
clear that research studies welcome those with access 
and mobility difficulties.’ ID 240 Other
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the future DesIgn AnD DelIVery Of PublIC InVOlVeMent 
In nIhr
Coordinate and collaborate
The NIHR was seen as a complex network of organisations 
that could benefit from a shared aim for PPI that under-
pins and informs the development of national policy 
supported by local practice. Some regions in England and 
Wales are already moving to a position where individuals 
from different organisations and programmes are joining 
to share knowledge and resources, to enhance their own 
practice.
‘Real progress in PPI will not be achieved without 
an effective mechanism for coordinating PPI efforts 
across the now many NIHR bodies that have a role 
in developing, fostering, or implementing PPI. It is 
essential there is a central body that will coordinate 
these efforts and will be responsible for ensuring that 
gaps do not occur, nor needless duplication.’ ID 24e 
Public
flexible evidence-based methods
Some respondents suggested that the methods of involve-
ment should be evaluated for their effectiveness. For 
example, the common practice of inviting one or two 
patients to join committees was perceived by some to be 
of limited value and likely to become less attractive as 
an approach. Many respondents felt that knowledge of 
the ‘ingredients’ of effective involvement needed to be 
developed.
‘Involve in the design and delivery as wide a constit-
uency as possible—those with 'knowledge', 'experi-
ence' and 'expertise', but also those who may be able 
to assist by asking questions, because they have differ-
ent backgrounds.’ ID 23e Researcher/Academic
Better identification of the key points where involve-
ment makes an impact was also regarded as important, 
particularly in relation to deciding research priorities, 
funding decisions, and translating findings into real bene-
fits for patients. The need for greater openness and trans-
parency in facilitating conversations with the public was 
also considered important. This would enable patients or 
members of the public to identify more collaborative or 
user-led approaches.
‘One of the most widely mentioned ‘metrics’ of im-
proved Public Involvement (PI) would be a growth 
in collaborative or user-led research. Suggestions for 
other specific indicators included: routine PI sections 
in annual reports and evaluation of PI in NIHR fund-
ed research project reports; increased representation 
of people from minority groups; and better recruit-
ment to trials (the latter two suggestions being of-
fered by public contributors).’ ID 15e RDS collective
Third sector representatives and community voluntary 
organisations were identified as potential partners who 
could more effectively engage with people locally and 
nationally;
‘The voluntary sector could play a key role in both 
the design and delivery of NIHR funded research. 
NIHR could establish much stronger links between 
research charities (such as the Wellcome Trust, 
Cancer Research UK, the McPin Foundation) and 
NIHR funded bodies in order to jointly commission 
and fund research.’ ID 35e Voluntary Sector.
Continuous improvement
Respondents felt there was a need to collect data to 
enable continuous improvement and not just perfor-
mance management.
‘What is required now is a national framework which 
sets minimum standards for PPI quality, against which 
funding and ethical approval decision making can be 
made. There should also be a move towards making 
incorporation of quality PPI work into funding appli-
cation bids standard for all reviewing bodies (as done 
by NIHR).’ ID 51e Other
DeVelOPIng A future VIsIOn
Many respondents, while recognising progress made so 
far, expressed the desire to be ambitious for the future. 
For some, this meant refining practice. For others, it was 
much more about reframing the purpose of involvement 
entirely, working differently and recognising the posi-
tive connections between engagement, involvement and 
participation.
Valued practice
Respondents felt that the debates about the need for 
public involvement should mature into discussions about 
what forms of involvement work in particular contexts. 
Individuals wanted to place their focus on improving the 
quality of their PPI in creating relevant research.
‘PPI should be routine—how things are done, not an 
optional extra. This should be embedded throughout 
the NHS so that all users of NHS services can expect 
that research evidence (is) supported by robust PPI. 
PPI isn’t simply an issue for research but for patient 
care, too.’ ID 15e RDS collective
‘By ten years, public involvement should have a much 
greater profile than what it has now. Members of the 
public and patients should know that we actively do 
research in an array of disease areas or conditions 
and that there are many opportunities for them to 
take part in this.’ ID 20e Public Involvement Lead/
Specialist
better evaluation and evidence
The importance of evidence was a key theme, particularly 
in relation to how to best evaluate public involvement and 
embedding it into research thinking and practice:
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‘The evidence base would be substantially enhanced 
so that there was a consensus between NIHR, senior 
researchers, the public and other stakeholders on the 
value of public involvement and the key factors nec-
essary to ensure effective involvement. We will have 
an agreed set of methods and indicators for assess-
ing the impact of public involvement that will have 
contributed to building a convincing evidence base. 
Public involvement would be so embedded in the cul-
ture of NIHR that new staff or new researchers com-
ing into the field would naturally take on the values 
and practices of effective public involvement.’ ID 40e 
Researcher/Academic
key concepts
Analysis of the themes emerging from the evidence 
submissions and synthesis of the data and discussion 
with the Review led to the development of a mission and 
vision as presented in (online supplementary appendix 
3). Three concepts for measuring success were suggested:
 ► Reach: the extent to which people and communities 
are engaged, participating and involved in NIHR 
research including the diversity of this population.
 ► Refinement and improvement: how public involve-
ment is adding value to research excellence as funded 
by the NIHR.
 ► Relevance: the extent to which public priorities for 
research are reflected in NIHR funding and activities.
 ► In addition to these three concepts, as the imple-
mentation of the recommendations has progressed, 
a fourth theme has emerged, relationships. This 
has been recognised as a significant determinant of 
success in strengthening public involvement.22
Underpinning these concepts is support for the princi-
ples of co-production as the basis of the NIHR’s approach 
in the future. These draw on the Boyle24 25 definition 
which emphasises the importance of developing close 
collaborations based on valuing people as assets with 
knowledge; recognising the expertise and perspective 
people bring to involvement; promoting good relation-
ships and networks; a perception that all people involved 
can benefit from public involvement; recognising that 
involvement often involves an exchange of some type; the 
process of involvement is important and requires facilita-
tion; that there is a need to change some of the profes-
sional boundaries that may inhibit more collaborative 
forms of work.
Implementing the review
In addition to the vision and mission, the Review led to a 
range of recommendations presented in (online supple-
mentary appendix 4), designed to strengthen co-produc-
tion and collaboration at the heart of research.
These recommendations are now being actively taken 
forward across the NIHR. ‘Going the Extra Mile’ was 
signed off by the Chief Medical Officer, Professor Dame 
Sally Davies, in September 2015 with an instruction to 
NIHR leaders, organisations and staff to support its 
implementation.19 This position has been supported with 
the decision by the Department of Health to regularly 
audit the NIHR’s progress in public involvement using 
the report recommendations as its starting point. Lines of 
responsibility and accountability for public involvement 
have been strengthened accordingly.
The INVOLVE Co-ordinating Centre’s future work 
programme reflects the priorities highlighted in the 
report and is the NIHR’s national lead of diversity and 
inclusion, learning and development and community 
(incorporating co-production). A national champion 
for diversity and inclusion has been appointed. The UK 
continues to be the only country where national govern-
ment funds and supports an organisation focused on 
public involvement in research.
INVOLVE, in partnership with the NIHR’s Research 
Design Services (RDS) organisation, is in the process of 
supporting and developing regional networks to facilitate 
collaborative working at local and regional level. These 
will connect with existing fora and partnerships and will 
reach across traditional research, services boundaries. 
Work is ongoing to refresh the way in which the NIHR 
presents its public involvement work beginning with the 
new corporate website.
A set of national standards designed to improve the 
quality and consistency of public involvement in research 
have been launched.26 These are based on a set of values 
and principles for public involvement published by 
INVOLVE in 2015 and a series of workshops to discuss 
how best to evolve standards that organisations can oper-
ationalise and against which progress can be assessed. A 
number of NIHR organisations will pilot these standards. 
This work will feed into emerging thinking about current 
reporting requirements on initiatives and how these can 
be improved in ways which will best promote continuous 
improvement. The Review Panel considered and rejected 
the notion of a formal regulatory regime for public 
involvement in favour of an approach which supported 
and encouraged organisations and their staff.
The programme of reform that is now underway is on 
top of ongoing innovation in public involvement activity 
generally. The expansion of the Patient Research Ambas-
sadors Initiative (PRAI) across the NHS, the involvement 
of young people in research, promotion of public contri-
bution to research through its ‘OK to Ask’ campaign, 
and growth of the James Lind Alliance Priority Setting 
Partnerships programme are all flagship initiatives which 
continue to receive support from the NIHR within the 
new strategic framework and approach.
DIsCussIOn AnD COnClusIOn
Arguably the NIHR is the leading public research funder 
globally when it comes to the steps it has taken to make 
public involvement a core principle for how it funds and 
supports research excellence. It is perhaps inevitable that 
it should therefore be the first to attempt a review of the 
size and scale of ‘Going the Extra Mile’.
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While the main focus was England, its messages have 
potential relevance for other countries developing their 
public involvement, reflecting wider societal changes 
towards a democratisation of research that enhances the 
quality of research. Public involvement in the NIHR has 
made significant progress in the last decade, enabled by 
a strong policy and infrastructure and implemented by a 
community of practitioners who recognise the value of 
actively involving patients and the public in research. We 
acknowledge the Review was limited to some extent by 
the lack of a formally conducted review of the literature 
and would recommend this for future policy reviews.
The Review identified a range of barriers including 
limited awareness of opportunities, lack of diversity, 
resistant attitudes to involvement, inconsistent levels of 
resources, systems that work in different ways, patchy 
training and support and variable organisational imple-
mentation. A key finding from the Review is the need 
for a step change, increasing the rate of change and 
with a greater focus on embedding public involve-
ment in research culture, so that it becomes ‘busi-
ness as usual’. The NIHR implementation plan is now 
starting to address this need but its ambition needs to 
be recognised as the rule and norms of research need 
to change for involvement to properly flourish. The 
Review was strengthened by the involvement of the 
Review Group, including the service users who ensured 
there was strong PPI in this example of evidence-in-
formed policy development.
While the focus was national, there are important inter-
national implications from the Review. Co-ordination and 
collaboration across organisations, funders and systems 
nationally and internationally to deliver high quality 
public involvement is vital. Public involvement needs to 
be underpinned by a strong evidence base which enables 
the development of effective practice that is continuously 
improved and creates a positive impact. The promotion 
of opportunities alongside the creation of greater diver-
sity of individuals involved will help ensure a wide range 
of voices are heard.
In analysing the evidence gathered for the Review, 
four new key concepts emerged of importance to the 
field of PPI; reach, refinement and improvement, rele-
vance and relationships. Relationships was added, in the 
implementation phase, as an additional key concept, 
vital to the delivery of the future vision. Reach refers to 
the extent of involvement, engagement and participa-
tion, ensuring diversity among members of the public 
who become involved. To achieve ‘reach’ researchers 
and research may need to work closely with the public 
to develop new ways of working to ensure diversity and 
inclusion are embedded within involvement. Relevance 
is focused on the extent to which public priorities for 
research are reflected in funding and activities. In an 
era of limited public funding, there is an ethical imper-
ative to ensure public monies are spent on research that 
patients feel has most relevance to their lives and the 
beneficial impact it may create. Relevance also refers to 
ensuring the research questions in a study are focused 
on what is acceptable and appropriate from the patient 
perspective. Drawing on evidence to refine practice 
through continuous improvement underpins attempts 
to develop relevance.
The thematic analysis underpinned the development of 
the vision of ‘Going the Extra Mile’, of a population actively 
involved in research to improve health and well-being 
for themselves, their family and their communities. The 
mission of ‘Going the Extra Mile’ is of the public as partners 
in everything we do to deliver high quality research that 
improves the health, well-being and wealth of the nation. 
Underpinning this future mission is the principles of 
co-production, which emerged as a new and important 
way of understanding the step change required in public 
involvement.24 25 At its heart is the co-production of 
knowledge and evidence through the creation of ways 
of working, cultures and systems that support this. From 
a research perspective, co-production offers a way of 
constructing ‘complete’ knowledge that includes all rele-
vant aspects of a concept.
‘In recent years an approach to research that em-
beds active participation by those with experience 
of the focus of that research has been championed 
both from the human rights perspective, that people 
should not be excluded from research that describes 
and affects their lives, and from a methodological 
perspective in terms of rigorous research: ‘… knowl-
edge constructed without the active participation of 
practitioners can only be partial knowledge.’27
We emphasise that co-production emerged from 
the Review and during the process we were not able to 
explore the concept fully. This in-depth exploration 
has been conducted by INVOLVE, drawing on a review 
of literature to inform the development of guidance on 
co-production and is now published.28 
In conclusion, ‘Going the Extra Mile’ challenges 
researchers, research and the organisations and institu-
tions that fund and promote it to go further in working 
alongside citizens. The Rome Declaration on Responsible 
Research and Innovation in Europe in November 2014 
emphasises the need to evolve a more inclusive approach 
to research.
‘Hence, excellence today is about more than 
ground-breaking discoveries—it includes openness, 
responsibility and the co-production of knowledge.’ 
p. 1
Our vision for the future is ambitious and may take 
many years to achieve. At its heart, there is a fundamental 
reorientation of research, its focus, how it is undertaken 
and how knowledge is created. As others have said, ‘if PPI 
were a drug, it would be malpractice not to prescribe it’. 
The benefits of co-production could lead us to a new era 
in research, one that is focused on the co-production of 
knowledge that benefits humanity in a new and funda-
mental way. Our ambition is that the ‘Going the Extra 
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Mile’ Review escalates such paradigm shift and contrib-
utes to changing the nature and role of research, for the 
benefit of patients, public and wider society.
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